Extended spectrum beta-lactamase production and susceptibility to antibiotics in Escherichia coli strains isolated from community acquired and nosocomial infections;Toplum kökenli̇ ve nozokomi̇yal i̇drar yolu enfeksi̇yonlarindan i̇zole edi̇len Escherichia coli suşlarinda geni̇şlemi̇ş spektrumlu beta-laktamaz varliǧinin araştirilmasi ve çeşi̇tli̇ anti̇bi̇yoti̇klere duyarliliklari

Mikrobiyoloji Bulteni

Volumn 35, Issue 3, 2001, Pages 351-357

  Tunger O ^a   Surucuoglu S ^a   Ozbakkaloglu B ^a   Gazi H ^a  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Double disk synergy method; Escherichia coli; Extended spectrum beta lactamases; Urinary tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CEFALOTIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NETILMICIN; OFLOXACIN; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DIFFUSION; ENZYME SYNTHESIS; ESCHERICHIA COLI; HOSPITAL INFECTION; METHODOLOGY; NONHUMAN; STRAIN DIFFERENCE; URINARY TRACT INFECTION;

EID: 18844465340     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mechanisms of bacterial antibiotic resistance
2. Beta-lactamases in laboratory and clinical resistance
3. A functional classification scheme for beta-lactamases and its correlation with molecular structure
4. Extended spectrum beta-lactamases and other enzymes providing resistance to oxymino beta-lactams
5. Amp C ve geniş spektrumlu beta-laktamazlarda son gelişmeler
6. Antibiyotik direnç mekanizmalari
7. Treatment failures with broad-spectrum antibiotics
8. Genetics of extended spectrum beta-lactamases
9. Extended-spectrum plasmid-mediated beta-lactamases
10. Oxa-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain
11. OXA-11, an extended spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa
12. Beta-lactam resistance in Gram-negative bacteria: Global trends and clinical impact
13. Clinical significance of extended-spectrum beta-lactamases
14. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended spectrum beta-lactamases
15. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp in a Belgian teaching hospital
16. Detection of extended spectrum beta-lactamases in Enterobacteriaceae in four French hospitals
17. Extended spectrum beta-lactamases
18. Çift disk sinerji yönteminde diskler arasi uzakliǧin sonuca etkisi
19. Gram negatif bakterilerde beta-laktamaz tipleri ve antibiyogramdan beta-laktamaz tipini tayin etmede kullanilabilecek yöntemler
20. Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime resistant Klebsiella pneumoniae
21. Hastane infeksiyonu etkeni Klebsiella pneumoniae ve Escherichia coli suşlarinin genişlemiş spektrumlu beta-laktamaz ve antibiyotik duyarlilik özelliklerinin araştirilmasi
22. Idrar yolu infeksiyonu etkeni gram negatif çomaklarda genişlemiş spektrumlu beta-laktamazlarin çift disk sinerji yöntemi ile belirlenmesi
23. Hastane infeksiyonu etkeni olarak soyutlanan Klebsiella pneumoniae ve Escherichia coli kökenlerinde genişlemiş spektrumlu beta-laktamaz sikliǧi
24. Hastane kökenli ve hastane dişi Escherichia coli lerde çift disk sinerji yötemiyle genişlemiş spektrumlu beta-laktamaz araştirilmasi ve izolatlarin çeşitli antibiyotiklere duyarlilik durumu
25. Nozokomiyal gram negatif bakterilerde genişlemiş spektrumlu ve kromozomal beta-laktamaz varliǧinin saptanmasi
26. Nozokomiyal gram negatif bakterilerde genişlemiş spektrumlu ve kromozomal beta-laktamaz sikliǧi
27. Aminoglycoside modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases